Day: November 18, 2020

Many choices. One unique portfolio. Building a diversified investment portfolio can be a complex process. From stocks, bonds and mutual funds to alternative investments such as hedge funds, a broad spectrum of investment vehicles is available to your The Tribbioli Group advisor in helping you develop a long-term financial plan. But building a portfolio is about more than just choices. It’s about making the right choices for you. Our advisors have the freedom to recommend only what they think makes the most sense for each client in building a diversified investment portfolio designed for your specific objectives. And those recommendations are powered by the expertise of our industry-leading research. From a solid mix of traditional options to a more complex blend of managed or alternative investments, there are plenty of choices when it...

BEVERLY, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that it has placed a MiQLab™ system into the clinical microbiology laboratory at the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet) as part of its Early Access Program. Penn Vet provides testing for animal patients at both the Ryan Veterinary Hospital and patients of practices across the US, processing thousands of samples each year.Dr. Jack Regan, LexaGene’s CEO and Founder, states, “We are very excited to be placing our first completed commercial MiQLab system in the Penn Vet microbiology laboratory for their evaluation. This is a tremendous step in delivering our technology...

Reference is made to the stock exchange notice in relation to the Written Resolution dated November 17 2020, proposing, amongst other items, a waiver from the dividend restriction to enable the transfer of up to 15% of the Company’s shares in Hexagon Purus to the shareholders of the Company, in conjunction with the intended Spin Off of Hexagon Purus.The proposed resolution was today adopted with the requisite majority. Please find attached the notice from Nordic Trustee AS.Hexagon highly appreciates the support from its bondholders in conjunction with the Written Resolution, which enables the spin-off of Hexagon Purus to be structured in a manner that maximizes value to all stakeholders.Carnegie AS and SEB acted as financial advisors for the Company.For further queries, please contact:David Bandele, CFO, Hexagon Composites ASATelephone:...

 See notice in the attachment. Attachment20201118_-_Skeljungur_-_RES_9_ehf._-_Flöggun

Sjá flöggunartilkynningu í viðhengi.Viðhengi20201118_-_Skeljungur_-_RES_9_ehf._-_Flöggun

MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced it commenced an offering of $500.0 million aggregate principal amount of senior notes (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Notes will be guaranteed, jointly and severally, on a senior unsecured basis, by certain of the Company’s subsidiaries.Syneos Health intends to use the net proceeds of the offering for general corporate purposes, including the funding of acquisitions and the repayment of indebtedness.The Company...